C4 Therapeutics (CCCC) Amortizatization of Intangibles (2019 - 2026)

C4 Therapeutics' Amortizatization of Intangibles history runs 8 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• In Q1 2026, Amortizatization of Intangibles rose 39.08% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $6.7 million (up 19.82% YoY), while the FY2025 annual figure was $6.4 million, changed 0.2% from the prior year.
• Amortizatization of Intangibles was $1.1 million for Q1 2026 at C4 Therapeutics, down from $1.4 million in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $4.0 million in Q3 2022 to a low of -$3.7 million in Q4 2022.
• Historically, Amortizatization of Intangibles has averaged $1.2 million across 5 years, with a median of $1.4 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Amortizatization of Intangibles tumbled 2175.0% in 2022, then soared 797.16% in 2024.
• A 5-year view of Amortizatization of Intangibles shows it stood at -$3.7 million in 2022, then surged by 142.46% to $1.6 million in 2023, then surged by 34.74% to $2.1 million in 2024, then slumped by 32.15% to $1.4 million in 2025, then slipped by 23.79% to $1.1 million in 2026.
• The last three Amortizatization of Intangibles figures came in at $1.1 million (Q1 2026), $1.4 million (Q4 2025), and $3.6 million (Q3 2025), per Business Quant data.